Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
84 hedge funds and large institutions have $11M invested in Ampio Pharmaceuticals Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 10 closing their positions.
2,814% more call options, than puts
Call options by funds: $204K | Put options by funds: $7K
52% more capital invested
Capital invested by funds: $7.24M → $11M (+$3.76M)
13% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 15
6% less funds holding
Funds holding: 89 → 84 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$332K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$316K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
+$187K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$76.6K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$62.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$109K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$60.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$57.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$44K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$37K |
AMPE Hedge Fund Activity: Q1 2019 in Review
84 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2019, worth a combined $11M — up 52% from $7.24M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AMPE and 5 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 17 added.
The largest buyer was BlackRock, adding an estimated $332K. The largest seller was Morgan Stanley, cutting an estimated $109K.
- 84 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2019, down from 89 in Q4 2018.
- Funds reported $11M of Ampio Pharmaceuticals Inc. stock for Q1 2019, up 52% quarter-over-quarter.
- 5 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2019 and 10 closed out, a net change of -5 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2019 was BlackRock, an estimated $332K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2019 was Morgan Stanley, an estimated $109K sold.
Based on aggregated 13F filings for Q1 2019.